Christopher R Self

Title: Christopher R Self: Innovator in Pharmaceutical Sciences

Introduction

Christopher R Self is a notable inventor in the field of pharmaceutical sciences. He has made significant contributions to the development of compounds and methods aimed at treating various diseases. His work primarily focuses on enhancing therapeutic approaches for conditions associated with T cell proliferation and other serious health issues.

Latest Patents

Christopher R Self has developed several innovative patents, including "Inhibitors Of Antigen Presentation By Mhc Class Ii Molecules And Methods Of Use Thereof." This invention relates to compounds and pharmaceutical compositions that are useful for treating or preventing diseases associated with T cell proliferation, such as autoimmune diseases and disorders. Another significant patent is "Improved Apo E Analogs And Methods For Their Use," which discloses novel ApoE peptide derivatives and conjugates. These innovations are aimed at treating disorders including CNS inflammation, traumatic brain injury, and Alzheimer's Disease, among others.

Career Highlights

Throughout his career, Christopher R Self has worked with various companies, including Provid Pharmaceuticals Inc. and Cognosci, Incorporated. His experience in these organizations has allowed him to advance his research and contribute to the development of important pharmaceutical solutions.

Collaborations

Christopher has collaborated with notable professionals in his field, including Charles M Cook. Their joint efforts have furthered research and innovation in pharmaceutical sciences.

Conclusion

Christopher R Self is a dedicated inventor whose work has the potential to impact the treatment of various diseases significantly. His innovative patents and career achievements highlight his commitment to advancing pharmaceutical sciences.